Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

718
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
718
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

198
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
198
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

252
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
252
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
183
Bioequivalence: Overview01:16

Bioequivalence: Overview

1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fully Automated Azeotropic Drying-Free Synthesis of [<sup>18</sup>F]SynVesT-1 via Copper-Mediated Fluorination Using the Trasis All-in-One Module.

Molecules (Basel, Switzerland)·2026
Same author

Interaction of Bacterial Histidine Phosphatase SixA With Phosphocarrier Protein NPr and Phosphohistidine Analogs.

Journal of molecular biology·2026
Same author

Suppression of AKT Activation Through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck Cancers.

Molecular cancer therapeutics·2026
Same author

Cassette-Based Automated Production of 2-Deoxy-2-[<sup>18</sup>F]fluorocellobiose on the Trasis AllInOne with Undetectable [<sup>18</sup>F]FDG Contamination.

Molecules (Basel, Switzerland)·2026
Same author

Correction to "Perfluorinated Iridium Catalyst for Signal Amplification by Reversible Exchange Provides Metal-Free Aqueous Hyperpolarized [1-<sup>13</sup>C]-Pyruvate".

Journal of the American Chemical Society·2026
Same author

SCaN: A Screening and Characterization Platform for Nanosuspensions Enables In Vivo Delivery of a Crystalline hRpn13<sup>Pru</sup> Degrader.

ACS pharmacology & translational science·2026

Related Experiment Video

Updated: Jul 1, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.0K

Structural Relationships to Efficacy for Prazole-Derived Antivirals.

David A Nyenhuis1, Susan Watanabe2, Rebecca Bernstein1

  • 1Biochemistry and Biophysics Center, NHLBI, NIH, 50 South Drive, Bld 50, Rm 3503, Bethesda, MD, 20892, USA.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|March 6, 2024
PubMed
Summary

New prazole derivatives inhibit viral production by targeting Tsg101. Modifications enhance efficacy against HIV-1 and SARS-CoV-2, with potential for improved drug half-life and specificity.

Keywords:
NMR spectroscopyantiviral agentsbiophysicsdrug designprotein modifications

More Related Videos

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.1K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K

Related Experiment Videos

Last Updated: Jul 1, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.0K
Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.1K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K

Area of Science:

  • Biochemistry
  • Virology
  • Medicinal Chemistry

Background:

  • Tsg101 is a key host factor in viral budding.
  • Prazole derivatives are being explored for antiviral properties.

Purpose of the Study:

  • To characterize prazole derivatives targeting Tsg101.
  • To evaluate their efficacy in inhibiting viral particle production.
  • To explore structure-activity relationships for enhanced antiviral effects.

Main Methods:

  • In vitro characterization of prazole derivatives.
  • Assays for viral particle production inhibition.
  • Analysis of Tsg101 adduct formation.
  • Structure-activity relationship studies.

Main Results:

  • Prazoles covalently bind to Tsg101's C73 site.
  • Increased steric bulk enhances inhibition of HIV-1 virus-like particle production.
  • Novel secondary Tsg101 adducts were formed, suggesting increased half-life and specificity.
  • Sulfide derivatives showed effective viral inhibition, targeting SARS-CoV-2.

Conclusions:

  • Prazole derivatives are promising antiviral agents targeting Tsg101.
  • Structural modifications can optimize antiviral activity and reduce toxicity.
  • Further development of these compounds could lead to new antiviral therapies.